Parastoo Jangouk1,2, Laura Turco1,2,3, Ana De Oliveira1,2,4, Filippo Schepis3, Erica Villa3, Guadalupe Garcia-Tsao1,2. 1. Section of Digestive Diseases, VA-Connecticut Healthcare System, West Haven, CT, USA. 2. Section of Digestive Diseases, Yale School of Medicine, New Haven, CT, USA. 3. Division of Gastroenterology, Azienda Ospedaliero-Universitaria di Modena and University of Modena and Reggio Emilia, Modena, Italy. 4. Department of Medicine, Federal University of Sao Carlos, Sao Carlos, Brazil.
Abstract
BACKGROUND: Guidelines recommend variceal screening in patients with cirrhosis to identify varices at high risk of bleeding requiring primary prophylaxis. Non-invasive criteria to rule out high-risk varices will avoid unnecessary endoscopies. Recent Baveno VI criteria define patients with compensated cirrhosis in whom endoscopy can be avoided as those with a liver stiffness by transient elastography <20 kPa and a platelet count >150 000/mm3. AIMS: To validate Baveno criteria in two cohorts with a different prevalence of high-risk varices and to determine whether alternate parameters not including liver stiffness would be equal/more accurate in ruling out high-risk varices. METHODS: Retrospective study evaluating patients with liver stiffness >10 kPa who had liver stiffness and endoscopy within 1 year of each other. RESULTS: This study included 161 patients from the US cohort (14 [9%] with high-risk varices) and 101 patients from an Italian cohort (17 [17%] with high-risk varices). Of patients meeting Baveno criteria (41 in the US, 16 in Italy), none had high-risk varices and therefore 26% (US) and 16% (Italy) endoscopies could have been avoided. Sensitivity and negative predictive value were 100%. A stepwise strategy using platelet count >150 000 and MELD=6, increased the number of endoscopies avoided to 54% (US) while maintaining a sensitivity and negative predictive value of 100%. Excellent sensitivity and negative predictive value were validated in the Italian cohort and in another cohort of patients with a clinical diagnosis of cirrhosis. CONCLUSIONS: This study validates Baveno VI criteria, particularly in sites with a low prevalence of high-risk varices and describes a new accurate strategy that does not include liver stiffness.
BACKGROUND: Guidelines recommend variceal screening in patients with cirrhosis to identify varices at high risk of bleeding requiring primary prophylaxis. Non-invasive criteria to rule out high-risk varices will avoid unnecessary endoscopies. Recent Baveno VI criteria define patients with compensated cirrhosis in whom endoscopy can be avoided as those with a liver stiffness by transient elastography <20 kPa and a platelet count >150 000/mm3. AIMS: To validate Baveno criteria in two cohorts with a different prevalence of high-risk varices and to determine whether alternate parameters not including liver stiffness would be equal/more accurate in ruling out high-risk varices. METHODS: Retrospective study evaluating patients with liver stiffness >10 kPa who had liver stiffness and endoscopy within 1 year of each other. RESULTS: This study included 161 patients from the US cohort (14 [9%] with high-risk varices) and 101 patients from an Italian cohort (17 [17%] with high-risk varices). Of patients meeting Baveno criteria (41 in the US, 16 in Italy), none had high-risk varices and therefore 26% (US) and 16% (Italy) endoscopies could have been avoided. Sensitivity and negative predictive value were 100%. A stepwise strategy using platelet count >150 000 and MELD=6, increased the number of endoscopies avoided to 54% (US) while maintaining a sensitivity and negative predictive value of 100%. Excellent sensitivity and negative predictive value were validated in the Italian cohort and in another cohort of patients with a clinical diagnosis of cirrhosis. CONCLUSIONS: This study validates Baveno VI criteria, particularly in sites with a low prevalence of high-risk varices and describes a new accurate strategy that does not include liver stiffness.
Authors: Edoardo G Giannini; Atif Zaman; Anna Kreil; Annarosa Floreani; Pietro Dulbecco; Emanuela Testa; Roya Sohaey; Peter Verhey; Markus Peck-Radosavljevic; Carlo Mansi; Vincenzo Savarino; Roberto Testa Journal: Am J Gastroenterol Date: 2006-10-04 Impact factor: 10.864
Authors: Annalisa Berzigotti; Guadalupe Garcia-Tsao; Jaime Bosch; Norman D Grace; Andrew K Burroughs; Rosa Morillas; Angels Escorsell; Juan Carlos Garcia-Pagan; David Patch; Daniel S Matloff; Roberto J Groszmann Journal: Hepatology Date: 2011-06-26 Impact factor: 17.425
Authors: Arun J Sanyal; Robert J Fontana; Adrian M Di Bisceglie; James E Everhart; Michael C Doherty; Gregory T Everson; John A Donovan; Peter F Malet; Savant Mehta; Muhammad Y Sheikh; Andrea E Reid; Marc G Ghany; David R Gretch Journal: Gastrointest Endosc Date: 2006-12 Impact factor: 9.427
Authors: Amir A Qamar; Norman D Grace; Roberto J Groszmann; Guadalupe Garcia-Tsao; Jaime Bosch; Andrew K Burroughs; Rie Maurer; Ramon Planas; Angels Escorsell; Juan Carlos Garcia-Pagan; David Patch; Daniel S Matloff; Robert Makuch Journal: Hepatology Date: 2008-01 Impact factor: 17.425